Lista de obras -

Acquisition of a side population fraction augments malignant phenotype in ovarian cancer

scientific article published on 02 October 2019

Anti-VEGF therapy resistance in ovarian cancer is caused by GM-CSF-induced myeloid-derived suppressor cell recruitment

artículo científico publicado en 2020

Antitumor Effect of Nivolumab on Subsequent Chemotherapy for Platinum-Resistant Ovarian Cancer

artículo científico publicado en 2018

Clinical efficacy of neoadjuvant chemotherapy with irinotecan (CPT-11) and nedaplatin followed by radical hysterectomy for locally advanced cervical cancer

artículo científico publicado en 2016

Comprehensive assessment of the expression of the SWI/SNF complex defines two distinct prognostic subtypes of ovarian clear cell carcinoma.

artículo científico publicado en 2016

Distinct preoperative clinical features predict four histopathological subtypes of high-grade serous carcinoma of the ovary, fallopian tube, and peritoneum.

artículo científico publicado en 2017

Establishment of a Novel Histopathological Classification of High-Grade Serous Ovarian Carcinoma Correlated with Prognostically Distinct Gene Expression Subtypes

artículo científico publicado en 2016

Exome Sequencing Landscape Analysis in Ovarian Clear Cell Carcinoma Shed Light on Key Chromosomal Regions and Mutation Gene Networks.

artículo científico publicado en 2017

Genomic profile predicts the efficacy of neoadjuvant chemotherapy for cervical cancer patients

artículo científico publicado en 2015

Hysteroscopic morphological pattern reflects histological grade of endometrial cancer

scientific article published on 09 May 2019

Invasion of uterine cervical squamous cell carcinoma cells is facilitated by locoregional interaction with cancer-associated fibroblasts via activating transforming growth factor-beta

scientific article published on 28 November 2014

Low-Grade Endometrial Stromal Sarcoma with a Nodule-in-Nodule Appearance in Preoperative Magnetic Resonance Images

scientific article published on 30 July 2020

Mucinous adenocarcinoma, gastric type of the uterine cervix: clinical features and HER2 amplification

scientific article published on 10 July 2018

PD-L1 on tumor cells is induced in ascites and promotes peritoneal dissemination of ovarian cancer through CTL dysfunction

artículo científico publicado en 2013

Phosphorylation of STAT1 serine 727 enhances platinum resistance in uterine serous carcinoma

artículo científico publicado en 2019

Placental sonic hedgehog pathway regulates foetal growth via insulin-like growth factor axis in preeclampsia

artículo científico publicado en 2019

Prediction of taxane and platinum sensitivity in ovarian cancer based on gene expression profiles

artículo científico publicado en 2016

Primary signet ring cell carcinoma of uterine cervix and related disease: two case reports and a review

artículo científico publicado en 2019

STAT1 drives tumor progression in serous papillary endometrial cancer.

artículo científico publicado en 2014

Snail promotes ovarian cancer progression by recruiting myeloid-derived suppressor cells via CXCR2 ligand upregulation.

artículo científico publicado en 2018

Survival outcome of stage I ovarian clear cell carcinoma with lympho-vascular space invasion.

artículo científico

The BMP signaling pathway leads to enhanced proliferation in serous ovarian cancer-A potential therapeutic target.

artículo científico publicado en 2015

The efficacy of secondary cytoreductive surgery for recurrent ovarian, tubal, or peritoneal cancer in Tian-model low-risk patients

artículo científico publicado en 2019

The mesenchymal transition subtype more responsive to dose dense taxane chemotherapy combined with carboplatin than to conventional taxane and carboplatin chemotherapy in high grade serous ovarian carcinoma: A survey of Japanese Gynecologic Oncology

artículo científico publicado en 2019

UGT1A1 polymorphism has a prognostic effect in patients with stage IB or II uterine cervical cancer and one or no metastatic pelvic nodes receiving irinotecan chemotherapy: a retrospective study

scientific article published on 05 August 2020

Unenhanced region on magnetic resonance imaging represents tumor progression in uterine carcinosarcoma

artículo científico publicado en 2017

VISTA expressed in tumour cells regulates T cell function

scientific article published on 09 November 2018

Venous thromboembolism, interleukin-6 and survival outcomes in patients with advanced ovarian clear cell carcinoma.

artículo científico publicado en 2015

[Perspectives of Individualized Treatment by Genome-Wide Analyses in Ovarian Cancer].

artículo científico publicado en 2016

Lista de obras de

Acquisition of a side population fraction augments malignant phenotype in ovarian cancer

Anti-VEGF therapy resistance in ovarian cancer is caused by GM-CSF-induced myeloid-derived suppressor cell recruitment

Antitumor Effect of Nivolumab on Subsequent Chemotherapy for Platinum-Resistant Ovarian Cancer

Clinical efficacy of neoadjuvant chemotherapy with irinotecan (CPT-11) and nedaplatin followed by radical hysterectomy for locally advanced cervical cancer

Comprehensive assessment of the expression of the SWI/SNF complex defines two distinct prognostic subtypes of ovarian clear cell carcinoma.

Distinct preoperative clinical features predict four histopathological subtypes of high-grade serous carcinoma of the ovary, fallopian tube, and peritoneum.

Establishment of a Novel Histopathological Classification of High-Grade Serous Ovarian Carcinoma Correlated with Prognostically Distinct Gene Expression Subtypes

Exome Sequencing Landscape Analysis in Ovarian Clear Cell Carcinoma Shed Light on Key Chromosomal Regions and Mutation Gene Networks.

Genomic profile predicts the efficacy of neoadjuvant chemotherapy for cervical cancer patients

Hysteroscopic morphological pattern reflects histological grade of endometrial cancer

Invasion of uterine cervical squamous cell carcinoma cells is facilitated by locoregional interaction with cancer-associated fibroblasts via activating transforming growth factor-beta

Low-Grade Endometrial Stromal Sarcoma with a Nodule-in-Nodule Appearance in Preoperative Magnetic Resonance Images

Mucinous adenocarcinoma, gastric type of the uterine cervix: clinical features and HER2 amplification

PD-L1 on tumor cells is induced in ascites and promotes peritoneal dissemination of ovarian cancer through CTL dysfunction

Phosphorylation of STAT1 serine 727 enhances platinum resistance in uterine serous carcinoma

Placental sonic hedgehog pathway regulates foetal growth via insulin-like growth factor axis in preeclampsia

Prediction of taxane and platinum sensitivity in ovarian cancer based on gene expression profiles

Primary signet ring cell carcinoma of uterine cervix and related disease: two case reports and a review

STAT1 drives tumor progression in serous papillary endometrial cancer.

Snail promotes ovarian cancer progression by recruiting myeloid-derived suppressor cells via CXCR2 ligand upregulation.

Survival outcome of stage I ovarian clear cell carcinoma with lympho-vascular space invasion.

The BMP signaling pathway leads to enhanced proliferation in serous ovarian cancer-A potential therapeutic target.

The efficacy of secondary cytoreductive surgery for recurrent ovarian, tubal, or peritoneal cancer in Tian-model low-risk patients

The mesenchymal transition subtype more responsive to dose dense taxane chemotherapy combined with carboplatin than to conventional taxane and carboplatin chemotherapy in high grade serous ovarian carcinoma: A survey of Japanese Gynecologic Oncology

UGT1A1 polymorphism has a prognostic effect in patients with stage IB or II uterine cervical cancer and one or no metastatic pelvic nodes receiving irinotecan chemotherapy: a retrospective study

Unenhanced region on magnetic resonance imaging represents tumor progression in uterine carcinosarcoma

VISTA expressed in tumour cells regulates T cell function

Venous thromboembolism, interleukin-6 and survival outcomes in patients with advanced ovarian clear cell carcinoma.

[Perspectives of Individualized Treatment by Genome-Wide Analyses in Ovarian Cancer].